Goldman Sachs Group Inc Ani Pharmaceuticals Inc Put Options Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ANIP
# of Institutions
209Shares Held
16.4MCall Options Held
24KPut Options Held
7.7K-
Black Rock Inc. New York, NY2.66MShares$159 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.35MShares$80.7 Million0.0% of portfolio
-
State Street Corp Boston, MA704KShares$42.1 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX655KShares$39.2 Million0.01% of portfolio
-
Ranger Investment Management, L.P. Dallas, TX590KShares$35.3 Million2.32% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.04B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...